BCCCP Prep Course (BCCCP): free quiz

1. Question 1 of 10

   DOMAIN: Shock And Organ Perfusion → Vasoactive selection. In an adult ICU patient with septic shock receiving norepinephrine 0.18 mcg/kg/min IV continuous infusion, MAP remains 58 mm Hg after 30 mL/kg crystalloid, lactate is 4.6 mmol/L, urine output is 0.2 mL/kg/hr, and telemetry shows atrial fibrillation with rapid ventricular response. As the critical care pharmacist, which vasopressor recommendation is most appropriate to improve perfusion while limiting further tachyarrhythmia risk?

   Choose one answer

   ARecommend adding vasopressin 0.03 units/min IV continuous infusion as a non-catecholamine adjunct to norepinephrine, with prompt reassessment of MAP, urine output, and lactate.BRecommend switching to dopamine IV continuous infusion because its beta activity may improve cardiac output and renal perfusion in septic shock.CRecommend adding epinephrine IV continuous infusion now because it provides additional alpha and beta stimulation and may raise MAP quickly despite the current tachyarrhythmia.DRecommend adding phenylephrine IV continuous infusion because pure alpha agonism is preferred routinely as the second-line vasopressor in septic shock.
2. Question 2 of 10

   A patient with suspected sepsis is started on empiric antimicrobials. Twelve hours later, the patient develops worsening hypotension and signs of organ dysfunction. Which pharmacist assessment is most important at this point?

   Choose one answer

   AReassess antimicrobial and supportive therapy in the context of evolving dysfunction and altered drug clearance.BStop reviewing pharmacotherapy because hypotension is unrelated to sepsis progression.CAssume toxicity risk is unchanged until all organ failure has resolved.DDefer all pharmacist recommendations because sepsis is not a critical care disease state.
3. Question 3 of 10

   Which statement best reflects the pharmacist's role when evaluating chronic regimens in a critically ill adult?

   Choose one answer

   AThe pharmacist should determine whether chronic medications require continuation or hold in the ICU plan.BThe pharmacist should avoid chronic medication review because it is outside treatment planning.CThe pharmacist should assume home medications are never related to instability.DThe pharmacist should assume baseline disease severity never changes monitoring.
4. Question 4 of 10

   An ICU pharmacist is developing a handoff note for a high-risk patient. Which wording best captures the source pack's risk recognition principle?

   Choose one answer

   AMultiple deterioration risk factors present; recommend targeted prophylaxis review and increased monitoring intensityBRisk factors documented; no change in monitoring because risk recognition is informational onlyCPolypharmacy present; organ dysfunction is not relevant to medication harmDRecent device exposure documented; this lowers the likelihood of deterioration
5. Question 5 of 10

   During status epilepticus management, the ICU pharmacist is asked to prepare an urgent medication. The order is consistent with the local protocol, but the medication route depends on available access. Which issue is the most important for the pharmacist to clarify before administration?

   Choose one answer

   AWhether the patient has appropriate access for the ordered route and timing.BWhether the medication can be delayed until routine pharmacy rounds.CWhether the pharmacist should independently diagnose the seizure cause.DWhether documentation can replace bedside dose verification.
6. Question 6 of 10

   An ICU pharmacist is asked to identify the BCCCP blueprint area most directly represented by IABP, Impella, and VAD support. Which blueprint category best matches this topic?

   Choose one answer

   ACritical Care: Medical Therapies and Devices, specifically mechanical circulatory supportBProfessional Practice: Human Subjects ResearchCTherapeutics and Patient Management: DermatologyDCritical Illness: Post-ICU Syndrome
7. Question 7 of 10

   A mechanically ventilated patient has received sedative, analgesic, and neuromuscular blocking medications. Which pharmacist monitoring priority best fits the selected node?

   Choose one answer

   AEvaluate how these therapies affect ventilation strategy, synchrony, delirium, and readiness for liberation.BTreat these therapies as unrelated to respiratory support.CAssume the ventilator eliminates the need to monitor adverse medication effects.DFocus exclusively on ventilator settings rather than medication exposure.
8. Question 8 of 10

   Which action would be least consistent with the selected ECMO pharmacotherapy principles?

   Choose one answer

   AIgnoring patient response because the patient is receiving ECMOBConsidering whether circuit sequestration may alter exposureCReviewing local ECMO dosing referencesDUsing concentrations when available to support assessment
9. Question 9 of 10

   A pharmacist is reviewing an ICU medication profile and notices that several medications are ordered through an enteral route. The patient has an enteral access device, but the anatomic location of the tube is unclear. What is the most important reason to clarify the tube location?

   Choose one answer

   ATube location can change dosage-form suitability and absorption expectations.BTube location determines whether line-associated infection prevention is unnecessary.CTube location confirms that all medications will have identical absorption.DTube location is relevant only to nursing documentation, not medication delivery.
10. Question 10 of 10

    A nurse asks whether a new infusion can be piggybacked into a line that is already running another medication. The pharmacist cannot confirm compatibility from available information. Which response is most appropriate?

    Choose one answer

    AProceed because the two medications will mix only briefly at the Y-site.BProceed if the patient has no history of medication allergy.CEscalate the unresolved compatibility question before connecting the infusion.DProceed if the new infusion is not a vesicant.

Check my answers